Effect of the Intensity of Continuous Renal Replacement Therapy in Patients With Acute Kidney Injury
Study Details
Study Description
Brief Summary
The current international Continuous Renal Replacement Therapy (CRRT) replacement fluid doses of 35 ml/kg/h is better, but the result is according to white people, black people . It is Whether the best amount of replacement fluid for Chinese people, it is unclear. Especially,there is little evidence about the optimal dose from randomized trials in Cardiac surgery associated acute kidney injury (CSA-AKI )required CRRT,According to the clinical situation, the design of replacement fluid to 25 ml/kg/h.The observation of two doses 14 days, 28 days, 90 days survival and renal function.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
Acute kidney injury (AKI) is a major complication in patients with cardiac surgery and is an independent predictor of mortality. However, the optimal intensity of renal replacement therapy for such patients is still controversial. we randomly assigned the patients with Cardiac surgery-associated acute kidney injury (CSA-AKI) to continuous renal replacement therapy with different treatment dose (35ml / kg / h or 25ml/kg/h),The primary study outcome was death from any cause within 14, 28 and 90 days.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: high dose (35ml/kg/h) > = 18 years of age, CRRT indications for acute kidney injury (RIFLE criteria) patients with cardiac surgery, was given filtration at a rate of 35 mL/kg/h. |
Device: CRRT
Difference dose of CRRT
|
Experimental: low dose (25ml/kg/h) > = 18 years of age, CRRT indications for acute kidney injury (RIFLE criteria) patients with cardiac surgery, was given filtration at a rate of 25 mL/kg/h. |
Device: CRRT
Difference dose of CRRT
|
Outcome Measures
Primary Outcome Measures
- death from any cause [14, 28 ,90 and 365 days after randomization]
The primary study outcome was death from any cause within 14, 28 ,90 and 365 days after randomization.
Secondary Outcome Measures
- renal outcome of survivors [14, 28 ,90 and 365 days after randomization]
Secondary outcomes were renal outcome of survivors14, 28 ,90 and 365 days after randomization
Eligibility Criteria
Criteria
Inclusion Criteria:
-
= 18 years of age, CRRT indications for acute kidney injury (RIFLE criteria) patients with cardiac surgery
Exclusion Criteria:
-
< 18 years old,
-
with chronic kidney disease,
-
dialysis history, to leave the ICU patients with acute kidney injury (AKI). - chronic kidney disease,
-
all causes kidney damage (pathology, hematuria, and radiographic abnormalities)> = 3 months or glomerular filtration rate < 60ml/min for 3 months or more.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Nephrology Department,Guangdong General Hospital | Guangzhou | Guangdong | China |
Sponsors and Collaborators
- Wei Shi
Investigators
- Principal Investigator: Wei Shi, MD, PhD, Guangdong Provincial People's Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LXL-CRRT2535